Polar Asset Management Partners Inc. Takes Position in Addus HomeCare Corporation $ADUS

Polar Asset Management Partners Inc. acquired a new position in Addus HomeCare Corporation (NASDAQ:ADUSFree Report) during the 2nd quarter, HoldingsChannel.com reports. The firm acquired 75,710 shares of the company’s stock, valued at approximately $7,607,000.

Several other large investors have also recently made changes to their positions in the stock. Royal Bank of Canada increased its holdings in Addus HomeCare by 24.3% in the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after purchasing an additional 1,347 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock valued at $1,026,000 after purchasing an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after purchasing an additional 2,952 shares in the last quarter. Jane Street Group LLC lifted its stake in Addus HomeCare by 387.6% during the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after purchasing an additional 8,780 shares in the last quarter. Finally, Intech Investment Management LLC boosted its position in shares of Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after buying an additional 4,439 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $121.09 on Wednesday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. Addus HomeCare Corporation has a 52-week low of $87.95 and a 52-week high of $124.43. The firm has a market cap of $2.26 billion, a PE ratio of 21.24, a price-to-earnings-growth ratio of 1.62 and a beta of 0.87. The company’s 50 day moving average is $110.51 and its two-hundred day moving average is $102.69.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping the consensus estimate of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The business had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. During the same quarter in the previous year, the firm posted $1.49 earnings per share. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. On average, research analysts expect that Addus HomeCare Corporation will post 6.29 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on ADUS. Barclays lifted their price objective on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Finally, Royal Bank Of Canada boosted their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $130.88.

View Our Latest Stock Analysis on Addus HomeCare

Insider Activity

In related news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 4.10% of the company’s stock.

About Addus HomeCare

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Further Reading

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.